Encompass Health Corporation $EHC Shares Acquired by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. grew its holdings in Encompass Health Corporation (NYSE:EHC) by 2.5% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 762,312 shares of the company’s stock after acquiring an additional 18,726 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned about 0.76% of Encompass Health worth $96,829,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in EHC. Tectonic Advisors LLC boosted its holdings in shares of Encompass Health by 1.6% in the 3rd quarter. Tectonic Advisors LLC now owns 5,337 shares of the company’s stock valued at $678,000 after buying an additional 82 shares in the last quarter. Global Retirement Partners LLC lifted its holdings in shares of Encompass Health by 23.0% in the 3rd quarter. Global Retirement Partners LLC now owns 449 shares of the company’s stock valued at $57,000 after purchasing an additional 84 shares during the last quarter. EP Wealth Advisors LLC boosted its position in shares of Encompass Health by 2.4% in the 2nd quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock valued at $453,000 after purchasing an additional 88 shares during the period. Natural Investments LLC grew its stake in Encompass Health by 1.2% during the 3rd quarter. Natural Investments LLC now owns 7,808 shares of the company’s stock worth $991,000 after buying an additional 89 shares during the last quarter. Finally, Securian Asset Management Inc. increased its position in Encompass Health by 1.3% during the second quarter. Securian Asset Management Inc. now owns 7,716 shares of the company’s stock worth $946,000 after buying an additional 100 shares during the period. 97.25% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

EHC has been the subject of several research analyst reports. Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Zacks Research downgraded shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Barclays upped their price target on Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research note on Thursday, October 30th. KeyCorp boosted their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a research note on Tuesday, September 16th. Finally, UBS Group upped their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Thursday, October 2nd. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $142.86.

Encompass Health Price Performance

Shares of NYSE EHC opened at $100.28 on Wednesday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.14. Encompass Health Corporation has a one year low of $91.33 and a one year high of $127.99. The firm has a market capitalization of $10.09 billion, a P/E ratio of 18.96, a PEG ratio of 1.65 and a beta of 0.74. The company’s fifty day moving average is $110.19 and its two-hundred day moving average is $116.68.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $1.23 EPS for the quarter, beating the consensus estimate of $1.19 by $0.04. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. The firm had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter last year, the business earned $1.03 earnings per share. The business’s revenue for the quarter was up 9.4% compared to the same quarter last year. Analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a dividend of $0.19 per share. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $0.76 annualized dividend and a yield of 0.8%. Encompass Health’s payout ratio is currently 14.37%.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.